CBDY
Target Group Inc.
Key Financials
Net Income
$-1359682
↓ 947.1%
EPS (Diluted)
$-0.00
↓ 1200.0%
Revenue
$3.9M
↓ 41.1%
Gross Profit
$2.1M
↓ 44.5%
Total Assets
$6.2M
↓ 18.4%
Shareholders' Equity
$-8062948.00
↓ 23.9%
Long-term Debt
$7.6M
↑ 5.0%
Cash & Equivalents
$10487.00
↓ 96.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/15/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 10-Q | 11/7/2025 | View on SEC |
| 8-K | 8/18/2025 | View on SEC |
| 10-Q | 8/12/2025 | View on SEC |
| 10-Q | 5/9/2025 | View on SEC |
| 10-K | 3/27/2025 | View on SEC |
| 10-Q | 11/7/2024 | View on SEC |
| 8-K | 8/26/2024 | View on SEC |
| 10-Q | 8/8/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CBDY |
| Company Name | Target Group Inc. |
| CIK | 1586554 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 905-541-3833 |